← Back to all trials
Not Yet Recruiting
NCT05627986
Sensorimotor Cortex Excitability in Shoulder Impingement Syndrome
Conditions: Shoulder Impingement Syndrome, Chronic Pain, Transcranial Magnetic Stimulation, Electroencephalography, Central Nervous System
Sex: All
Ages: 20 Years – 65 Years
Healthy volunteers: 1
Enrollment: 100
Sponsor: National Yang Ming University
Summary
Shoulder pain is a common musculoskeletal system complaint, accounting for 7-34% of patients in the clinic.
The most common shoulder problem is subacromial impingement syndrome (SIS).
Up to 45% of individuals with SIS may have unsuccessful treatment and still complain of symptoms after 2 years.
This chronicity of pain may not be fully explained by structural injuries or damage, but may be related to sensorimotor changes.
Decreased corticospinal excitability and increase inhibition have been found in individuals with SIS.
These central motor changes may link to alteration in pain and nociception processing and the somatosensory system, which has been found in individuals with low back pain.
Hyperalgesia has been found over both affected and unaffected shoulders in patients with SIS, indicating central and peripheral sensitization.
However, no study has investigated whether there are changes in the central somatosensory system.
Therefore, the objectives of this proposal are (1) to investigate the corticomotor and somatosensory system in patients with SIS (2) to investigate the relationship between the corticomotor and somatosensory alterations in patients with SIS.
Subjects with chronic SIS and healthy subjects were recruited, with 32 people in each group.
Electroencephalography (EEG) will be used to collect somatosensory activity, including somatosensory evoked potentials, spectral analysis of EEG oscillations and event-related spectral perturbation (ERSP) of the shoulder movement.
Electromyography will be used to record muscle activity.
Transcranial magnetic stimulation will be used to test corticomotor excitability, including active motor threshold, motor evoked potentials, cortical silent period, and intracortical inhibition and facilitation.
The pressure pain threshold will be collected by a pressure algometer on the muscles of bilateral arms and legs.
Pain intensity will be assessed with the Numeric Rating Scale.
Shoulder function will be evaluated with the Disability of Arm, Shoulder and Hand questionnaire.
Depression will be evaluated with Center for Epidemiologic Studies Depression Scale (CES-D).
Eligibility Criteria
Inclusion Criteria (chronic impingement syndrome group):individuals have shoulder pain localized at the anterior or lateral aspect of shoulder more than six monthsare aged 20 to 65 years oldshoulder impingement syndrome, which is confirmed by having at least three of the following: (a) positive Neer's test, (b) positive Hawkins-Kennedy test, (c) positive empty can test, (d) positive resisted external rotation test, and (e) presenting painful arc during arm elevationInclusion Criteria (acute/subacute impingement syndrome group):individuals have shoulder pain localized at the anterior or lateral aspect of shoulder less than six monthsare aged 20 to 65 years oldshoulder impingement syndrome, which is confirmed by having at least three of the following: (a) positive Neer's test, (b) positive Hawkins-Kennedy test, (c) positive empty can test, (d) positive resisted external rotation test, and (e) presenting painful arc during arm elevationInclusion Criteria (health control group)individuals without any shoulder and neck problemssex, age, and hand dominance match to impingement groupExclusion Criteria:have a history of dislocation, fracture, adhesive capsulities, or surgery of upper extremityarm elevation angle less than 150 degreesa history of direct contact injury to the neck or upper extremities within the past 12 monthsbrain injury and neurological impairmentinflammatory cause of the pain (e.g., rheumatoid arthritis)neck painpsychosis and symptom of headache or dizzinessallergy to plastercontraindications to the use of TMS, assessed with a safety screening questionnaire
Source: ClinicalTrials.gov (NCT05627986). StuddyBuddy aggregates publicly available trial information.